ReviewThe Lancet. Oncology2025
National cancer control plans in Latin America and the Caribbean: challenges and future directions.
Review in The Lancet. Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Independent cancer research in low- and middle-income countries: why it matters and how to build it.The oncologist · 2026Review
- The global epidemiology of hepatocellular carcinoma.Hepatology communications · 2026Review
- The early impact of the COVID-19 pandemic on access to colorectal cancer treatment in Brazil: a spatial and interrupted time-series analysis.Lancet regional health. Americas · 2026Article
- Accelerating the elimination of cervical cancer: cross-sectional examination of cancer prevention and control in Latin America and the Caribbean.Lancet regional health. Americas · 2026Article
- The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection.Ecancermedicalscience · 2026Review
- Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022.Cancer research communications · 2025Article
- [2018-2024 Cancer Trends in Pathology of a Hospital in Eastern Mexico].Revista medica del Instituto Mexicano del Seguro Social · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
14 authors.
Funding
Abstract
In this Policy Review, we examine cancer incidence and mortality rates across Latin America and the Caribbean, focusing on national cancer control plans (NCCPs) as frameworks for reducing the cancer burden in the region. By 2022, only 16 countries had active NCCPs, with eight being cancer specific and eight being integrated into public health plans. Our analysis found that dedicated NCCPs were linked to reduced cancer incidence but not reduced mortality. Broader socioeconomic indicators, such as universal health coverage and a higher Human Development Index, were more strongly associated with improved cancer outcomes, including reduced mortality-to-incidence ratios. Prevention measures such as cervical cancer screening and compliance with WHO's MPOWER tobacco control strategies also reduced cancer incidence, underscoring the importance of public health policies. However, challenges including insufficient cancer registries, underfunding, and health-care inequities hinder NCCP implementation. Addressing these gaps requires sustainable registries, regional evaluation frameworks, global collaboration, and stronger political commitment to ensure the success of NCCPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.